The Biomarkers Consortium created new ways for stakeholders to work together. It defined a pre-competitive space for drug manufacturers, biotechnology companies, regulators, public research agencies, academics, patient advocacy groups & trade organi…
I was also part of a collaboration that wrote about how such institutions might be built - https://t.co/3PiksFQjyk
Five ways consortia can catalyse open science https://t.co/GhvrORFUgn https://t.co/LFe9PCAf7N
Five ways consortia can catalyse open science https://t.co/DKj2ynKjLy https://t.co/27QfBJoNWt